数据链接：
官方服务：
资源简介：
Potential factors influencing adherence to ART.
影响抗逆转录病毒治疗（Antiretroviral Therapy，ART）依从性的潜在因素
应用场景：
创建时间：
2015-12-02
相关数据集
ATN 024 Antiretroviral Medications: Other Antiretroviral Medication Listing [CRF 4] Dataset in A Randomized, Open-Label Trial of Three Hepatitis B Vaccination Schemas in HIV-Positive Youth
Data from Antiretroviral Medications Form: Other Antiretroviral Medication Listing [CRF 4] Study Description Suboptimal response to hepatitis B vaccination in HIV-positive adults and children has been
NIAID Data Ecosystem70
ATN 061 Chemistry Results Primary Dataset in Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/ritonavir (ATV/r) in Adolescents and Young Adults with CD4 + T Cells > 350 cells/mm3 Initiating HAART
Data from Chemistry Results Form [CRF 11, questions 1-2, 3-4, 5, and 6 and 6a for version 1] Study Description A randomized, proof-of-concept study of adolescents and young adults aged 18-24 years wit
NIAID Data Ecosystem40
Antiretroviral medication regimens in included studies.
*PMTCT prophylaxis refers to the use of ARV drugs solely for the purpose of reducing the risk of vertical transmission when a woman is not on standard ART for therapeutic reasons.Antiretroviral medica
Figshare2015-12-02 更新10
Performance of Baseline Adherence Measures as Predictors of ART Failure at 12 Months.
MPR: Medication possession ratio; PDC: Proportion of days covered; TVR: Timely visit ratio; VAS: Visual analogue scale; %NoMD: Proportion of visits with no missed dose reported; AUC: Area under the re
NIAID Data Ecosystem50
Baseline characteristics of participants (per protocol cohort, n = 122).
1 Mean (standard deviation)2 n = 117 for all participants, n = 59 for ARV-naïve and n = 58 for ARV-user3 Median (IQR)4 n = 116 for all participants, n = 57 for ARV-naïve and n = 59 for ARV-user* Stati
Figshare2015-12-03 更新10
